Seth Puneet, Yeowell Heather N
Duke University Medical Center, Durham, North Carolina 27710, USA.
Arthritis Rheum. 2010 Apr;62(4):1167-75. doi: 10.1002/art.27315.
Scleroderma (systemic sclerosis [SSc]) is a complex connective tissue disorder characterized by hardening and thickening of the skin. One hallmark of scleroderma is excessive accumulation of collagen accompanied by increased levels of pyridinoline collagen crosslinks derived from hydroxylysine residues in the collagen telopeptide domains. Lysyl hydroxylase 2 (LH2), an important alternatively spliced enzyme in collagen biosynthesis, acts as a collagen telopeptide hydroxylase. Changes in the pattern of LH2 alternative splicing, favoring increased inclusion of the alternatively spliced LH2 exon 13A, thereby increasing the levels of the long transcript of LH2 (LH2[long]), are linked to scleroderma disease. This study was undertaken to examine the role played by RNA binding protein Fox-2 in regulating exon 13A inclusion, which leads to the generation of scleroderma-associated LH2(long) messenger RNA (mRNA).
Phylogenetic sequence analysis of introns flanking exon 13A was performed. A tetracycline-inducible system in T-Rex 293 cells was used to induce Fox-2 protein, and endogenous LH2(long) mRNA was determined by reverse transcriptase-polymerase chain reaction. An LH2 minigene was designed, validated, and used in Fox-2 overexpression and mutagenesis experiments. Knockdown of Fox-2 was performed in mouse embryonic fibroblasts and in fibroblasts from SSc patients.
Overexpression of Fox-2 enhanced the inclusion of exon 13A and increased the generation of LH2(long) mRNA, whereas knockdown of Fox-2 decreased LH2(long) transcripts. Mutational analysis of an LH2 minigene demonstrated that 2 of the 4 Fox binding motifs flanking LH2 exon 13A are required for inclusion of exon 13A. In early passage fibroblasts derived from patients with scleroderma, the knockdown of Fox-2 protein significantly decreased the endogenous levels of LH2(long) mRNA.
Our findings indicate that Fox-2 plays an integral role in the regulation of LH2 splicing. Knockdown of Fox-2 and other methods to decrease the levels of fibrosis-associated LH2(long) mRNA in primary scleroderma cells may suggest a novel approach to strategies directed against scleroderma.
硬皮病(系统性硬化症[SSc])是一种复杂的结缔组织疾病,其特征为皮肤变硬和增厚。硬皮病的一个标志是胶原蛋白过度积累,同时胶原蛋白端肽结构域中源自羟赖氨酸残基的吡啶啉胶原蛋白交联水平升高。赖氨酰羟化酶2(LH2)是胶原蛋白生物合成中一种重要的可变剪接酶,作为胶原蛋白端肽羟化酶发挥作用。LH2可变剪接模式的改变,有利于增加可变剪接的LH2外显子13A的包含,从而增加LH2长转录本(LH2[long])的水平,这与硬皮病相关。本研究旨在探讨RNA结合蛋白Fox-2在调节外显子13A包含中的作用,外显子13A的包含会导致与硬皮病相关的LH2(long)信使核糖核酸(mRNA)的产生。
对外显子13A侧翼的内含子进行系统发育序列分析。在T-Rex 293细胞中使用四环素诱导系统诱导Fox-2蛋白,并通过逆转录聚合酶链反应测定内源性LH2(long)mRNA。设计、验证了一个LH2小基因,并将其用于Fox-2过表达和诱变实验。在小鼠胚胎成纤维细胞和SSc患者的成纤维细胞中敲低Fox-2。
Fox-2的过表达增强了外显子13A的包含,并增加了LH2(long)mRNA的产生,而敲低Fox-2则降低了LH2(long)转录本。对LH2小基因的突变分析表明,LH2外显子13A侧翼的4个Fox结合基序中的2个是外显子13A包含所必需的。在硬皮病患者来源的早期传代成纤维细胞中,敲低Fox-2蛋白显著降低了内源性LH2(long)mRNA的水平。
我们的研究结果表明,Fox-2在LH2剪接调节中起不可或缺的作用。在原发性硬皮病细胞中敲低Fox-2以及其他降低纤维化相关LH2(long)mRNA水平的方法,可能提示一种针对硬皮病的新策略方法。